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Reoxygenation following ischemia causes tissue oxidative
stress. We studied the role of oxidative stress caused by
kidney ischemia/reperfusion (I/R) on the mitochondria of
renal tissue slices. I/R caused the mitochondria to be swollen,
fragmented, and have lower membrane potential. The
mitochondria generated more reactive oxygen species (ROS)
and nitric oxide (NO) in situ as measured by fluorescence of
ROS- and NO-sensitive probes. Infusion of lithium ion, an
inhibitor of glycogen kinase synthase-3, caused
phosphorylation of its Ser-9 and restored the membrane
potential and decreased ROS production of the mitochondrial
fraction. Ischemic kidney and hypoxic rat preconditioning
improved mitochondrial membrane potential and lowered
ROS production caused by subsequent I/R similar to lithium
ion infusion. Preconditioning normalized NO production in
mitochondria as well. The drop in the mitochondrial
membrane potential was prevented by NO synthase
inhibition, demonstrating a strong contribution of NO to
changes in mitochondrial energy metabolism during the I/R
transition. Mitochondria in the I/R-stressed kidney contained
less cytochrome c and more pro-apoptotic Bax, consistent
with apoptotic degradation.
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Prominent among the current models of oxidative stress is
the one that occurs as a result of reoxygenation following
hypoxia. It can be observed in a number of vital organs (e.g.,
heart, brain, kidney) experiencing a lack of oxygen due to
pathological limitation of the oxygen supply (pharmaco-
logical vasoconstriction, thrombosis, anemia) followed by its
restoration. This change can have a lethal effect resulting in a
loss of cell viability and can lead to malfunctioning of the
entire organ. Oxidative stress-induced cell death apparently
involves mitochondria in a primary role. These organelles are
considered to be one of the major sources of the cellular
reactive oxygen species (ROS), possibly providing a delicate
balance between intracellular and intramitochondrial ROS
production and use. Such a balance, when shifted to a very
low ROS level by the excessive use of antioxidants,1 or to a
very high level due to oxidative stress,2 may cause
pathological and even lethal effects both in the mitochondria
and the host cell.3–5 Thus, the general strategy for cell survival
basically requires the maintenance of an optimally low ROS
level. The implementation of a particular strategy for defense
against oxidative stress critically demands lowering the
ROS level, mostly through the regulation of mitochondrial
ROS production.
Mitochondria are known to generate ROS mainly by the
respiratory chain6–10 residing in the inner membrane, by
matrix-located dehydrogenases11 and by outer membrane-
located monoamine oxidase.12 A mitochondrial transition
pore-mediated ROS-induced ROS-release5 may occur in
mitochondria by any of these mechanisms; however, there
is a trend to consider that the respiratory chain is responsible
for this process.13–16 Evidently, it reflects the conversion of
signaling ROS into pathological ROS. Signaling ROS make a
significant contribution to the cell’s antioxidative stress
defense (in hypoxic/ischemic preconditioning (PC)), while
pathological ROS primarily contribute to cell degradation.
The transition from a signaling to a pathological ROS level
may be significantly delayed through the regulatory mechan-
ism of ischemic PC in the heart.17,18 The key role for this
defense mechanism belongs to glycogen synthase kinase-3
(GSK-3) where defensive signaling mechanisms are con-
verged in the vicinity of the mitochondrial permeability
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transition (MPT) pore. Understanding this mechanism enables
one to outline a local strategy for preventing cell death, which
should be designed to avoid the induction of the MPT. Some of
the afore-mentioned mechanism may be at work in the
brain,19–23 although there is no report of the occurrence of
the same cascade in the nephron. The main aim of the present
study is to elucidate nephroprotective mechanisms to minimize
damage caused by ischemia/reoxygenation.
RESULTS
Changes in mitochondrial structure and functioning in kidney
cells
Tetramethylrhodamine ethyl ester (TMRE) fluorescence
intensity demonstrates a rather heterogeneous pattern of
distribution over mitochondria in the kidney slice belonging
to different cells. Rough averaging of the total TMRE
fluorescence over the slice was used as an average index of
the mitochondrial energization in that tissue. Kidney
ischemia followed by restoration of blood flow (ischemia/
reoxygenation, I/R) resulted in a dramatic loss of the
mitochondrial membrane potential over the kidney cells
(about 60% by the TMRE fluorescence intensity compared to
control values, Figure 1a–c). Also, the mitochondrial func-
tional heterogeneity, seen with occasional solitary cell islets
with normal TMRE fluorescence after I/R, was much more
apparent than in the control sample (Figure 1a and b). The
dramatic loss of the mitochondrial membrane potential that
occurs as a result of I/R was significantly blocked by the MPT
inhibitor, cyclosporin A (CSA; Figure 1c).
In control slices, mitochondria exhibited the typical
filamentous pattern (Figure 1d) observed independently on
the sectioning plane (not shown). In some cases after I/R, the
TMRE staining was punctuated, apparently demonstrating
mitochondrial fragmentation (Figure 1f). Mitochondria in
the kidney exposed to I/R demonstrated a significant volume
increase (Figures 1e and 7a), which is an attribute of MPT
in vitro. Electron microscopy also revealed dramatically
swollen mitochondria in I/R kidney cortex sections (Figure
1h), compared to normal, orthodox mitochondrial ultra-
structure in the control kidney (Figure 1g).
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Figure 1 | Mitochondrial membrane potential in rat kidney cells. TMRE staining. (a) Control kidney section. (b) Section from the kidney
exposed to I/R. (c) Mitochondrial transmembrane potential evaluation; CSA (1 mM) was introduced into the section bath medium together
with TMRE. (d) High zoom of the area in (a) highlighting mitochondria in tubular cells. Note filamentous form of mitochondria (arrowheads).
(e) High zoom of the area in (b). Mitochondria are swollen and de-energized (arrowheads). Often mitochondrial fragmentation (arrowheads)
can be seen in tubular cells from kidney exposed to I/R (d). Electron micrographs (g) of intact rat kidney cortex and (h) of that after I/R
demonstrate swollen mitochondria in kidney exposed to I/R. Bars¼ 100mm (a and b), 10 mm (d–f), and 1 mm (g and h). *Po0.01 I/R vs control;
**Po0.01 I/R plus CSA vs I/R.
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ROS and nitric oxide bursts in cells from kidney slices
exposed to I/R
ROS production examined by 20,70-dichlorodihydrofluores-
cein diacetate (DCF) fluorescence in renal tissue exposed to
I/R was about doubled as compared to the control sample
(Figure 2, see also Figure 4b). The most obvious changes in
ROS production were revealed in tubular cells. Digital
analysis of fluorescence intensity in confocal images showed
that DCF fluorescence profiles were colocalized with
mitochondria (Figure 2), demonstrating that mitochondria
are responsible for the ROS burst caused by I/R.
Cellular nitric oxide (NO) production evaluated by DAF-2
fluorescence was quite low in control kidney samples,
whereas I/R resulted in a dramatic increase in fluorescence
(from 9.570.5 to 33.070.8 AU, Figure 3a). The pretreatment
of slices from rats exposed to I/R with L-nitroarginine,
resulted in a general loss of DAF fluorescence, which indicates
the critical role of nitric oxide synthase (NOS) in the NO
burst following I/R. The DAF-2 signal originates from
mitochondria as it is strictly colocalized to the TMRE signal
(Figure 3), thus revealing the mitochondrial origin of the NO
burst caused by I/R.
Protective effect of Liþ on I/R-induced damage: role of GSK-3
As shown in cardiac myocytes, a key role in the process of
ischemic PC belongs to GSK-3b,17 where a number of
protective signaling pathways converge. Since Liþ blocks the
activity of GSK-3, it explains the protective effect of Liþ ,
which makes it potentially useful for other tissue models
including kidney exposed to I/R. When rats received LiCl
intraperitoneal (50 mg kg1) before renal ischemia, mito-
chondrial membrane depolarization in tubular cells caused
by I/R was reduced significantly (Figure 4a). Considering the
CSA sensitivity of the I/R-induced transmembrane potential
(Dc) loss, we suggested that the protective effect of Liþ
infusion was due to a lower probability of MPT induction
that takes place in cardiac myocytes.17 Since MPT induction
in cardiac myocytes caused an ROS burst (ROS-induced
ROS-release5), any means of protecting from MPT induction
will potentially lower excessive ROS production in the heart
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Figure 2 | ROS generation in rat kidney sections. (a–c and e)
DCF(H2)-DA staining; (d and e) TMRE staining. (a and c) Control
kidney. (b and d) Kidney exposed to I/R. (c–e) High zoom of a region
from (b). Colocalization of ROS and mitochondrial dye is shown in e
(arrowheads point to distinct mitochondria) and (f) as a match of
profiles of two signals over a randomly chosen line in the image from
(e). Bars¼ 100mm (a and b) and 10mm (c–e).
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Figure 3 | NO production in the rat kidney sections. (a) NO
production is higher in cells from kidney exposed to I/R. NOS
inhibitor, L-NAME (5 mM), eliminates both gross NO rise caused by I/R
and basal NO production. LiCl infusion prior to I/R does not affect
the gross NO rise. (b–e) Tubular cells from kidney exposed to I/R.
DAF-2-DA and TMRE staining. Bar¼ 10mm. Colocalization of NO and
mitochondrial dye is shown in d (arrowheads point to distinct
mitochondria) and (e) as a match of profiles of two signals over a
randomly chosen line in the image from (d). *Po0.01 I/R vs control.
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cell. That was also the case for kidney cells because Liþ
treatment before renal ischemia resulted in a remarkable
decrease in DCF fluorescence and, hence, in less oxidative
stress after I/R (Figure 4b). Direct evidence that the Liþ
effect is directed toward GSK-3b activity in kidney cells
derives from the fact that LiCl infusion led to the
accumulation of serine-9 phosphorylated GSK-3b form
(Figure 4c), which is known to be inactive.24 While total
GSK-3b level stays unchanged (Figure 4d), the latter result
indirectly shows that GSK-3b kinase activity must be lower
than in control samples.
The same trend was observed in isolated mitochondria
(Figure 4e). When mitochondria were taken from kidneys
exposed to I/R, they displayed significantly lower Dc values.
If the kidney was exposed to ischemia following Liþ
pretreatment, Dc was higher when compared to ischemia
alone. The difference in the degree of the membrane potential
recovery after the Liþ supplement (Figure 4a and e) may be
due to a different level of complexity of isolated mitochon-
dria and tissue slices.
Experiments on the measurement of adenosine tripho-
sphate (ATP) content in the kidney slice demonstrate that
I/R causes significant loss of cellular ATP level. After
40-min ischemia, ATP and adenosine diphosphate (ADP)
levels dropped to 0.7870.03 mmol g1 tissue and 0.637
0.03 mmol g1 tissue, correspondingly, as compared to
2.6670.08 mmol g1 tissue and 0.8670.06 mmol g1 tissue
in control tissue. Adenosine monophosphate content in
ischemic kidney rose from 1.0270.02 to 1.9670.04 mmol g1
tissue. After 40-min reperfusion, kidney ATP, ADP,
and adenosine monophosphate content was 0.9270.04,
0.7170.02, and 1.6370.04, correspondingly. Advanced LiCl
infusion prior to ischemia did not show significant effect on
nucleotides level when compared with ischemia alone (data
not shown).
Effects of PC on post-ischemic changes in renal cortex
PC is the most potent form of protection capable of reducing
cell death caused by I/R. In vital organs, conventional PC
protection is induced by brief episodes of transient ischemia
and reperfusion preceding the prolonged ischemic insult.
Since Liþ treatment mimics PC (referred to as pharmaco-
logical PC) in both cardiac myocytes17 and kidney tissue (this
study), we compared the effects of pharmacological PC
caused by Liþ to those of ischemic PC (caused by brief
episodes of ischemia) applied to an organ and of hypoxic PC
(caused by brief episodes of hypoxia) applied to an animal.
Figure 5a demonstrates that the mitochondrial Dc decline
after I/R (30% of the control) was moderately restored by
ischemic PC (to 56%; Figure 5a), while hypoxic PC resulted
in a much higher Dc restoration (78% of the control). ROS
production in kidneys exposed to ischemic PC followed by
I/R was diminished as compared to kidneys exposed to I/R
alone (Figure 5b). Exposure of rats to brief periods of
hypoxia reduced I/R-induced ROS-release to approximately
66% of controls (Figure 5b).
Hypoxic PC also had an effect on NO production in
tubular cells after I/R. Compared to controls, kidney slices of
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Figure 4 | GSK-3b role in kidney protection. (a and b) Mitochondrial membrane potential and ROS production correspondingly in kidney cells
after LiCl infusion to the animal before ischemic insult. (c) Phosphorylated GSK-3b (P-GSK-3b) and (d) total GSK-3b changes in isolated
mitochondria of control kidney and of that after Liþ infusion. (e) Transmembrane potential of isolated mitochondria from kidney exposed to
I/R (dark gray line) or I/R with Liþ pretreatment (light gray line). At 0 time, 5 mM succinate was added resulting in mitochondrial energization.
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (15 nM) acutely abolished the safranine signal in all samples. *Po0.01 I/R vs
control; **Po0.01 I/R plus Liþ vs I/R.
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rats exposed to brief periods of hypoxia before I/R
demonstrated a nearly 50% decrease in DAF-2 fluorescence
(Figure 5c).
Influence of mitochondrial NOS on respiratory chain
functioning
One of the most potent regulatory effects of NO is the
slowing of respiration through cytochrome c oxidase
inhibition.25 Typically, the effect of NO on mitochondria is
studied by using artificial NO donors, although the results
may not reflect the physiological effect of naturally formed
NO.26 In the current work we investigated the role of
endogenous NO produced in mitochondria on oxygen
consumption in vitro.
Using uncoupled rat kidney mitochondria respiring with
succinate, we found that supplementation with calcium ions
and L-arginine elicits an apparent decrease in respiration rate
(Figure 6b). Under these conditions, Ca2þ alone (300 mM)
does not produce any changes in respiration.
It is known that reactive nitrogen species can inhibit not
only cytochrome oxidase, but other respiratory chain
complexes as well.27 To investigate this possibility under
our conditions, TMPD/ascorbate was used as a substrate in
experiments where electrons were donated only to the
terminal respiratory chain complex. Moreover, broken
mitochondria (produced by three cycles of freezing/thawing
of the initial mitochondrial suspension containing 30–40 mg
of protein per ml) were used to avoid the influence of ion and
substrate transport on NOS activity. The mitochondrial
respiration rate under optimal conditions for NO synthesis
was 0.6170.02 mM O2 per second, and with the NOS
inhibitor, No-nitro-L-arginine methyl ester (L-NAME),
it was higher (0.7170.02 mM O2 per second). Thus,
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Figure 5 | Effect of PC on the mitochondrial functional state in
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Figure 6 | Evidence that NO synthase is involved in the regulation
of mitochondrial activity. (a) Mitochondrial transmembrane
potential changes (by TMRE fluorescence) in the sections of the
kidney exposed to I/R. NO synthase inhibitor, L-NAME, was
supplemented to the kidney section incubation medium. (b) Effect of
NO synthase substrate on the respiration of isolated kidney
mitochondria (0.2 mg protein per ml). Solid line, O2 changes in the
incubation medium; thin line, respiration rates changes. 5 mM
succinate, 15 nM (carbonylcyanide p-trichloromethoxyphen-
ylhydrazone (CCCP)), 300mM CaCl2, and 5 mM L-arginine were added
as shown. *Po0.01 I/R vs control; **Po0.01 I/R plus L-NAME vs I/R.
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NO-induced inhibition of TMPD/ascorbate-supported re-
spiration was about 14%, and we conclude that a major part
of the respiratory inhibition by NO is explained by its
interaction with cytochrome c oxidase.
Similar data were obtained in renal cortex slices when the
effect of NO overproduction on mitochondrial Dc was
tested. While I/R caused Dc to decrease, the treatment of
slices with L-NAME restored it to about 50% of control
(Figure 6a). It is assumed that the Dc loss under these
conditions can be mediated through the elevation of NO
production, particularly by mitochondria.
Activation of apoptotic pathways in kidney cells exposed to I/R
We propose that kidney cells exposed to acute ischemia can
activate an apoptotic cascade. To test this hypothesis, we
carried out immunohistochemical staining of formaldehyde-
fixed renal cortex slices with anti-Bax antibodies. Cells from
control kidneys showed a diffuse distribution of Bax protein
in the cytoplasm (Figure 7b). After ischemia and 10-min
reperfusion, we frequently observed compartmentalization of
Bax in tubular cells, which is presumably due to swollen
mitochondria. One hundred and eighty minutes reperfusion
after ischemia induced a significant translocation of Bax
into these compartments with marginal cytosolic staining
(Figure 7c). Bax-positive compartments were identified using
antibodies against cytochrome oxidase, a mitochondrial
membrane marker. Double staining of the kidney sections
after ischemia and 180-min reperfusion with anti-Bax
and anti-cytochrome oxidase antibodies revealed total
colocalization of these proteins, appearing as a complete
coincidence of fluorescence peaks (Figure 7e). In the
mitochondrial fraction from kidneys exposed to I/R, the
amount of Bax was raised by 50% compared to controls,
while cytochrome c content in the same mitochondrial
samples decreased to about 40% (Figure 7d).
DISCUSSION
The primary aim of this study was to investigate kidney cell
function under conditions closely approximating the in vivo
situation. For this, we used vital kidney slices, which have the
advantage of preserving the complex architectural relations
between different cells in the tissue. A disadvantage is that
damage occurs to superficial cells in the slice. Because
conventional confocal microscopy makes use of the plane of
fully intact cells next to the damaged layer, the presence of the
damaged cells is not expected to have a strong effect on the
characterization of cell function obtained by this method. At
the same time, fluorescence microscopy always requires
exposure to excitation light causing ROS generation, and
hence possible mitochondria/cell damage. To exclude this, we
minimized the impact of photo-induced damage by lowering
the exposure to excitation light and by analyzing images
obtained only after the first laser scans. Carefully taking all
this into account, we believe that the kidney slice is a more
attractive model for studying mitochondrial behavior than
isolated organelles taken from the kidney or dissociated cells
in culture. We also found kidney slices to be a reliable model
in which to test ischemia/reoxygenation as a means of
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Figure 7 | Immunohistochemical staining of sections from the kidney cortex. (a) Staining with antibodies against Bax. Note that in the
control kidney, Bax is scattered over the cytosol, after ischemia followed by a 10-min reperfusion (b) Bax is compartmentalized in swollen
mitochondria. (c) Exceptional mitochondrial localization of Bax 3 h after I/R is obvious. Bar¼ 10 mm. (d) Immunoblotting of Bax and cytochrome
c in isolated kidney mitochondria after ischemia followed by a 10-min reperfusion. Total protein concentration is 40 mg per lane in all samples.
Densitometry analysis of Bax and cytochrome c spots in western blot confirmed an increase of Bax (Po0.05) and a decrease of cytochrome c
content (Po0.1) in the mitochondrial samples after I/R. (e) Mitochondrial Bax localization is confirmed by its colocalization with cytochrome
oxidase (a random line taken over the section immunostained with antibody against Bax and the IV subunit of cytochrome oxidase shows
coincidence of the distribution profiles).
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producing oxidative stress. Since mitochondria potentially
have a major role in responding to and producing oxidative
stress, our main focus has been on these intracellular
organelles with multiple known intracellular functions.28
Our results show that in control tissue slices there is an
essential heterogeneity in mitochondrial functional activity
manifested as variations in TMRE fluorescence between cells.
Just as we observed occasional cells possessing lower
mitochondrial membrane potential in control slices, so slices
from kidneys exposed to I/R have occasional cells with
mitochondrial membrane, indistinguishable from control
values (Figure 1a). Such heterogeneity clearly shows the
generalized, rather than total cellular and mitochondrial
damage caused by I/R. In this context, the deleterious effect
of I/R does not have a general effect on only local regions of
the tissue, but apparently leaves some cells and mitochondria
functioning normally.
I/R-induced mitochondrial fragmentation in the cell is a
prime example of mitochondrial degradation and compart-
mentalization. The phenomenon of the induced fragmenta-
tion of mitochondrial reticulum was observed for the first
time in cells after application of the mitochondrial benzo-
diazepine receptor ligand,29 and was later documented for a
number of mitochondrial inhibitors.30 Currently, fragmenta-
tion of mitochondrial reticulum is shown to present during
apoptosis,31 and is taken to be an indicator of apoptotic
degradation of the cell.32,33
Oxidative stress in the kidney caused by I/R resulted in a
dramatic loss of the mitochondrial membrane potential
throughout the tissue. This effect was significantly blocked by
CSA, that is it was apparently due to the MPT-induction, the
phenomenon earlier reported for isolated mitochondria34,35
and later ascribed to an apoptotic step, possibly resulting in a
mitochondrial release of pro-apoptotic factors.36–38 Mito-
chondria in kidney cells exposed to I/R demonstrated a
significant volume increase (Figures 1g, h and 7a), which is
also an attribute of MPT in vitro (reviewed in Zoratti and
Szabo39). The similarity of general mitochondrial fragmenta-
tion caused by benzodiazepine in the cultural kidney
epithelial cells29 and by I/R in a whole kidney supports the
idea that MPT may be the functional state of the
mitochondrial benzodiazepine receptor.40,41
The first direct evidence for a net ROS production increase
caused by I/R was obtained in the heart,42 and was suggested
to be the causative effect determining cell degradation.43,44
The mitochondrial origin of the ROS burst under I/R
supports the key role of mitochondria in the production of
signaling and pathological ROS.5,17 MPT induction caused by
renal I/R evidently triggers elevated ROS production.
Apparently, this ROS burst accompanied by MPT induction
can be explained by the phenomenon known as ‘ROS-
induced ROS-release’, first described in cardiac myocytes.5
Although the mechanism of excessive ROS production
accompanying MPT remains unknown, the importance of
this phenomenon in apoptotic cell degradation is widely
appreciated.45–47 In renal tissue, the possibility that
ROS-induced ROS-release is responsible for the observed
excessive ROS production during I/R and the decrement of
ROS generation after Liþ infusion preceding I/R serves as
additional evidence for MPT involvement in the process of
I/R-induced changes within the kidney.
Besides ROS, NO and other reactive nitrogen species were
reported to have a critical role in I/R injury. Indeed, the
protective role of NOS inhibitors against reoxygenation-
induced damage has been well demonstrated.48–50 Following
the discovery of a general mitochondrial NOS activity,51 it
was identified as belonging to a neuronal isoform, or NOS-1,52
a potential target for pharmacological intervention to
normalize the NO level in the cell and mitochondria.
However, the question whether NO, even at the high level
supported by I/R, serves a signaling or destructive function
remains open.
In our study, we have demonstrated that in the kidney I/R
causes nitrosative stress in addition to oxidative stress.
Consequently, mitochondria are not only the origin, but
also the target of this stress. Nitrosative stress results in a
slowing down of respiration (mainly through the interaction
of NO with cytochrome oxidase), which, in concert with
accelerated ROS production, lowers the efficacy of proton
pumping. Nitrosative stress caused by I/R in the kidney is
relieved by NOS inhibitors (both respiration and mitochon-
drial membrane potential are restored). This makes mito-
chondrial NOS an attractive target for future pharmacologic
interventions that would rescue the kidney from the oxidative
stress caused by I/R.
One of the most potent forms of protection against the
deleterious effects of I/R is tissue adaptation (e.g., through
ischemic or pharmacological PC). In the case of both
ischemic (ischemic training by transiently blocking the blood
supply to the kidney) and hypoxic (exposure of the rat to
brief episodes of hypoxia) PC, we were able to protect the
kidney by partial restoration of the mitochondrial membrane
potential, and by lowering ROS and NO production
(Figure 5). In pharmacological practice, a number of drugs
are widely used to mimic ischemic PC and thus serve to
minimize the cell damage induced by the hypoxia–normoxia
transition.
In cardiac myocytes, the ranking of drugs positive for
imitation of ischemic PC17 revealed that the protective
signaling pathways converge on a key enzyme, GSK-3b,
located in the vicinity of the permeability transition pore
complex.53,54 Liþ is an effective inhibitor of GSK-3b and its
use mimics PC in cardiac myocytes.17 The key role of GSK-3b
in protective signaling pathways in the heart indirectly
pointed to the importance of this kinase in protection
developed in other organs. Quite recently, GSK-3b activation
was shown to promote neuronal apoptosis, while kinase
inhibition may enhance neuroprotection.19–23 In this study,
LiCl infusion in the rat before the ischemic insult caused a
partial restoration of the mitochondrial membrane potential
(Figure 4a and e) and a reduction in mitochondrial ROS
production (Figure 4b), while not having a significant effect
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on I/R-induced NO production (Figure 3a). These protective
effects correlated with the appearance of the phosphorylated
form of GSK-3b (Figure 4c and d), which corresponds to its
inhibition.28
Mitochondria evidently play a crucial role in the
mechanism of I/R-induced kidney damage as well as in the
signaling protective mechanism. The observed mitochondrial
changes (namely, the loss of the mitochondrial membrane
potential, mitochondrial fragmentation, accelerated mito-
chondrial ROS, and NOS production which is correlated with
MPT induction) resemble those occurring with apoptotic
degradation. The interplay between mitochondrial cyto-
chrome c and pro-apoptotic Bax is accepted widely.55,56
Translocation of Bax to mitochondria causes the release of
cytochrome c and was proved to be a general event in the
apoptotic activation cascade in different models.55,57 Accord-
ing to our results, I/R in the kidney activates an apoptotic
cascade with a key role for MPT, ROS, reactive nitrogen
species, and GSK-3b. Thus, blockade of any of these four
factors can be considered as nephro-protective measures that
rescue kidney tissue from the deleterious effects of I/R injury.
MATERIALS AND METHODS
Animals
Experiments were performed on outbred white male rats
(180–200 g) fed ad libitum. Animal protocols were approved by
the Institutional Review Boards. Rats were anesthetized with sodium
pentobarbital (50 mg kg1, intraperitoneal). Unilateral renal arteries
were clamped by a microvascular clip for 40 min, and then
circulation was restored by removing the clip. Some of the rats
received LiCl (50 mg kg1, intraperitoneal) dissolved in Ringer’s
solution 30 min before ischemia. At 10 min (or, 180 min in some
cases) after reperfusion, the renal arteries were clamped and kidneys
were isolated. Renal cortex tissue slices B200 mm thick were cut
with a blade and placed into Hanks solution containing 10 mM
Hepes-NaOH, pH 7.4, with an appropriate concentration of
fluorescent probes. Sham-operated rats were used as controls.
Ischemic PC was performed by exposure to three 5-min episodes
of the renal artery clamping alternating with 5-min restoration of
the blood flow 10 min before the 40 min-long ischemia.
Hypoxic PC was performed by daily exposure of an animal to a
hypoxic (91% N2þ 9% O2) episode starting from 30 min in the first day
with steady increasing of the exposure time to 60 min in the last 5th day.
Confocal microscopy
Experiments were carried out at 251C except where otherwise
indicated. Kidney slices were imaged with an LSM510 inverted
confocal microscope (Carl Zeiss Inc., Jena, Germany) in a multi-
channel mode as appropriate for the dyes loaded. Analysis of
fluorochrome incorporation was performed in glass-bottom dishes
with the excitation at 488 nm (for DCF and fluorescein isothiocya-
nate) and 543 nm (for TMRE), and emission collected at
500–530 nm and 4560 nm, respectively. To minimize the contribu-
tion of photo-induced mitochondria/cell damage in the relative
fluorescence intensities, we analyzed images used by averaging the
first four scans only. Images were processed by ImageJ software
(W Rasband, NIH, Bethesda, MD, USA, http://rsb.info.nih.gov/ij).
Mitochondrial membrane potential determination in situ
Mitochondrial membrane potential was evaluated by using a
permeant cationic fluorescent probe.58,59 Slices were loaded with
1 mM TMRE (Molecular Probes Inc., Eugene, OR, USA) for 10 min at
room temperature, followed by 5 min of washing in Hanks solution.
A thresholded series of images were processed in ImageJ software to
obtain the relative intensity of the TMRE fluorescence.
ROS determination
Kidney slices were loaded with 10mM DCF-H2 DA (Molecular
Probes Inc.) for 10 min at room temperature followed by 5 min of
washing in Hanks solution. In certain protocols, cells were co-loaded
with 1 mM TMRE for 10 min at room temperature to permit
concurrent measurement of the mitochondrial membrane potential
and ROS production.
Intracellular NO determination
Kidney slices were loaded with 10 mM 40,50-diaminofluorescein
diacetate (DAF-2-DA, Calbiochem, San Diego, CA, USA) and
analyzed as for DCF. In certain protocols, cells were co-loaded with
1 mM TMRE for 10 min at room temperature to allow concurrent
measurements of mitochondrial membrane potential and NO levels.
Membrane potential and respiration rate determination in
isolated mitochondria
Kidney mitochondria were isolated by homogenization and
differential centrifugation in a medium containing 250 mM sucrose,
20 mM Hepes-NaOH, 1 mM EGTA, 0.5% bovine serum albumin
(BSA), pH 7.4. Membrane potential of isolated mitochondria was
measured using safranine, as described.60 Mitochondria were
suspended in incubation solution (250 mM sucrose, 10 mM Hepes-
NaOH, 5 mM KH2PO4, 2 mM MgCl2, 10 mg ml
1 rotenone, pH 7.4)
with 10 mM safranine and energized by the addition of 5 mM
Na-succinate.
The effect of NOS activation on mitochondrial respiration was
studied in a medium similar to the incubation solution. After
reaching the maximal linear respiration rate following carbonylcya-
nide p-trichloromethoxyphenylhydrazone (15 nM) addition, the
mitochondrial suspension was supplemented with 300 mM CaCl2
and 5 mM L-arginine. Respiration was recorded in an Oxygraph-2k
(Austria) chamber.
Western blot analysis
Kidney tissues were fractionated after disruption with glass-teflon
homogenizer in a medium containing 250 mM sucrose, 20 mM
Hepes-NaOH, pH 7.4, 1 mM EDTA, 10 mM dithiothreitol, 10 mM
phenylmethylsulfonylfluoride, 10 mM leupeptin, and 10 mM aprotinin
at 41C. The homogenate was centrifuged at 1000 g for 10 min and the
supernatant was centrifuged at 10 000 g for 10 min to prepare
mitochondrial fraction. The samples of mitochondria were normalized
for protein content (40mg per lane) by the bicinchoninic acid protein
assay,61 run on a 15% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gel and blotted onto a polyvinylidene difluoride
membrane (Amersham Pharmacia Biotech, Rainham, UK). Membranes
were blocked with 5% (wt/vol) non-fat milk in 100 mM Tris-HCl (pH
7.5), 0.9% NaCl, 0.1% (v/v) Tween 20, subsequently incubated with
mouse anti-cytochrome c (Pharmingen, San Diego, CA, USA), rabbit
anti-Bax (Santa Cruz, Santa Cruz, CA, USA), mouse anti-GSK-3b (Cell
Signaling Technology Inc., Danvers, MA, USA) and rabbit anti-P-GSK-
3b (Cell Signaling Technology Inc.) primary antibodies and stained
with anti-mouse IgG or anti-rabbit IgG conjugated with horseradish
1500 Kidney International (2007) 72, 1493–1502
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peroxidase (Calbiochem). Spots density analysis in the blot was
made by ImageJ software after scanning the membrane.
Immunohistochemistry
Kidney slices were washed in phosphate-buffered saline (PBS), fixed
for 60 min in 4% formaldehyde with PBS at 41C and stored in 1%
formaldehyde in PBS at 41C. The slices were permeabilized in PBS
containing 0.1% Triton X-100 for 15 min followed by blocking in
PBS containing 1% PBS-BSA for 60 min.
Bax was detected using rabbit anti-Bax polyclonal antibodies
(Santa Cruz) diluted 1:200 in PBS-BSA at 41C overnight. After three
15-min rinses in PBS-BSA, the slices were incubated for 1 h in
fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Sigma,
St Louis, MO, USA) diluted 1:100. Following three additional 15-
min rinses in PBS-BSA, the slices were incubated with mouse anti-
cytochrome oxidase (IV subunit) (Molecular Probes, Eugene, OR,
USA) monoclonal antibodies diluted 1:200 in PBS-BSA under the
same conditions. Three 15-min washes in PBS-BSA were followed by
incubation for 1 h in a secondary anti-mouse IgG antibody
conjugated with Cy5 (Jackson Immunology, West Grove, PA,
USA) diluted 1:200 in PBS-BSA. The slices were washed three times
in PBS and placed on microscope slides. The PBS was replaced with
mountain medium (50% glycerol on PBS) and slices were sealed
beneath cover slips with nail varnish.
ATP, ADP, and adenosine monophosphate determination
ATP and ADP quantification was performed using high-pressure
liquid chromatography. Briefly, renal extracts were made from tissue
by immediate homogenizing in ice-cold perchlorate acid (1 ml of
0.6 N HClO4/10 mg of tissue). The samples were maintained on ice,
capped, and centrifuged at 21C at 1500 g for 12 min. Then, samples
were neutralized, centrifuged at 21C at 1000 g for 15 min, and
filtered through a nylon filter. The samples were loaded on columns
and the ATP and ADP were separated by high-pressure liquid
chromatography (Millichrom, Novosibirsk, Russia). Detection was
performed at a peak wavelength of 260 nm. The peaks were
quantified by area under the curve and compared against peak
areas of known standards of ATP and ADP.
Electron microscopy
For electron microscopic study, 1 mm3 sections of renal cortex were
fixed by 2.5% glutaraldehyde prepared on a phosphate buffer (pH
7.2) with postfixation by 1% osmium tetroxide, dehydration in
ethanol, staining with uranyl acetate, and embedding in Epon 812.
Ultrathin sections were prepared on an LKB-3 ultramicrotome and
examined at 75 kV in a Hitachi HU-12 electron microscope.
Statistics
All experiments were performed at least in triplicate, with a cell
number X12 in each independent experiment unless otherwise
stated. All data are mean7s.e.m. Comparisons within groups were
made by an appropriate Student t-test, and Pp0.05 was taken to
indicate statistical significance.
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